Navigation Links
Cinergy Health Commentary on Senate Healthcare Vote
Date:12/21/2009

AVENTURA, Fla., Dec. 21 /PRNewswire/ -- Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs for the consumer market, expressed its concern for the ongoing healthcare debate and vote in the Senate, which passed early this morning.

"While the Senate and House healthcare bills are far from perfect, the Monday morning vote is at least a step towards expanding access to affordable health coverage for all Americans," said Daniel Touizer, CEO of Cinergy Health. "However, true healthcare reform needs to address the real root issue, which is prevention and education," Touizer said.

"We can't lose sight of our ultimate goal, which is to improve the health of all Americans," said Dr. Margaret Lewin, medical director of Cinergy Health. "As a physician I hope finally to be compensated financially for the extraordinary amount of time my staff and I spend providing quality patient care, working with providers and communicating with patients and family, and providing preventive and early detection services," Lewin said.

Cinergy Health offers unique, affordable alternatives to exorbitant insurance premiums for individuals and families, regardless of income or health condition. Plans are designed to encourage people to seek care when needed, not to delay or deter them such that their condition could worsen.

About Cinergy Health


SOURCE Cinergy Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cinergy Health Expands Staff in Face of Dramatic Growth
2. Cinergy Health Appoints Dr. Erika Schwartz as Medical Director
3. Cinergy Health Commentary On President Obamas Call for Cost Control, Competition in Health Insurance Arena
4. Cinergy Health Commentary on Americas Prescription Addiction
5. Cinergy Health Names Dr. Margaret Lewin Chief Medical Director
6. Cinergy Health Commentary on Health Care for the Unemployed
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2014)... policymakers consider ways to ease prohibitions on marijuana, the ... over the past century may provide valuable lessons, according ... that legalized marijuana in Colorado and Washington for recreational ... how to best allow the production, sales and the ... related social ills. , A new study published online ...
(Date:4/20/2014)... Researchers may have identified key genes linked to why ... others, according to a study released today that will ... Annual Meeting in Philadelphia, April 26 to May 3, ... it provides an objective way to understand pain and ... study author Tobore Onojjighofia, MD, MPH, with Proove Biosciences ...
(Date:4/18/2014)... The Gerontologist reports that among older Christians, ... in anxiety about death and increases in life satisfaction, ... particular, listening to gospel music is associated with a ... sense of control. , These associations are similar for ... both low- and high-socioeconomic status. , The article, titled ...
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently received ... in metastatic breast cancer reduces both the growth of ... scientists have found in models of the disease that ... 80 percent and can keep the tumor from metastasizing ... grant comes from the National Cancer Institute of the ...
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
Breaking Medicine News(10 mins):Health News:Regulating legal marijuana could be guided by lessons from alcohol and tobacco, study says 2Health News:Low tolerance for pain? The reason may be in your genes 2Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2
... that only 2 in 5 seek any assistance, ... being,one of today,s most common disorders, it is regularly ... occasional feelings of anxiety -- muscle tension,headache, nausea, fatigue, ... speaking, first dates, or during times of stress such ...
... Diseases (NIAID), part of the National Institutes of ... Clinical Proteomics Centers for Infectious Diseases and Biodefense. ... Texas Medical Branch (UTMB), Galveston, and to the ... centers will analyze human blood and other tissue ...
... launch anticipated in early 2009 -, CORONA, ... WPI ), a leading specialty pharmaceutical,company, announced today ... approved RAPAFLO(TM) (silodosin), the company,s new alpha blocker ... BPH., BPH is the number one reason ...
... Celestial,Group, Inc. (Nasdaq: HAIN ), a leading ... today announced that Irwin Simon, President and,Chief Executive ... the,Company on Wednesday, October 15, 2008 at the ... http://www.newscom.com/cgi-bin/prnh/20050324/NYTH131 ), The investor presentation ...
... Robbins & Myers, Inc.,(NYSE: RBN ) ... a regular,cash dividend payment of $0.0375 per share. ... shareholders of record as of October 20, 2008., ... supplier of engineered equipment and,systems for critical applications ...
... Oct. 8 New physical activity guidelines,released today ... Services (HHS),will give Americans the information they need ... of the USA, the national resource office for ... Activity Guidelines for Americans set achievable,goals for everyone ...
Cached Medicine News:Health News:40 Million Americans Endure Anxiety Everyday 2Health News:NIAID awards contracts to search for protein markers of disease 2Health News:Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH) 2Health News:Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH) 3Health News:Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH) 4Health News:Hain Celestial to Present at Canaccord Adams Healthy Living Naturally Boston Conference on October 15, 2008 2Health News:YMCA of the USA Supports New National Physical Activity Guidelines 2
(Date:1/15/2014)... Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), a ... a non-invasive, wireless continuous glucose monitoring system, today announced ... Interim CEO of Echo Therapeutics, will present at "TEN", ... Mr. Doman will make a corporate presentation ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... Jan. 15, 2014  Zafgen, Inc., a leading biopharmaceutical ... severely obese patients, today announced initial results from ... inhibitor of methionine aminopeptidase 2 (MetAP2), in patients ... genetic obesity.  These results showed improvements in body ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Argos Therapeutics announced today that interleukin ... dendritic cell (DC) immunotherapy and can be used as a ... company,s lead product, AGS-003, in metastatic renal cell carcinoma (mRCC). ... Immunotherapy demonstrate that the potency of mature CD40L RNA electroporated ...
... Rotational molder REMCON Plastics is already seeing process reduction ... organized under the leadership of new hire Benjamin F. ... REMCON,s Lean Manufacturing and Continuous Improvement Initiatives. He will ... active teams to sustain a strong, lean culture within ...
Cached Medicine Technology:Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics' Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial 2Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics' Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial 3Six Sigma Black Belt and Lean Sensei Ben Wittich Joins REMCON Plastics 2
Double-ended. Designated most popular model or size....
Designated most popular model or size. 3 mm tip....
Octagonal handle. 3 mm wide....
4 mm x 6 mm dissector end with shaft marked at 10 mm, 20 mm, 30 mm from tip. 6 mm wide curved elevator. Round knurled handle....
Medicine Products: